Your browser doesn't support javascript.
A longitudinal community-based ototoxicity monitoring programme and treatment effects for drug-resistant tuberculosis treatment, Western Cape.
Stevenson, Lucia J; Biagio-de Jager, Leigh; Graham, Marien A; Swanepoel, De Wet.
  • Stevenson LJ; Department of Speech-Language Pathology and Audiology, Faculty of Humanities, University of Pretoria, Pretoria. luciaj.stev@gmail.com.
S Afr J Commun Disord ; 69(1): e1-e13, 2022 Mar 31.
Article in English | MEDLINE | ID: covidwho-1776408
ABSTRACT

BACKGROUND:

 South Africa has a high burden of drug-resistant tuberculosis (DRTB) and until recently, ototoxic aminoglycosides were predominant in treatment regimens. Community-based ototoxicity monitoring programmes (OMPs) have been implemented for early detection of hearing loss and increased patient access.

OBJECTIVES:

 A longitudinal study was conducted to describe the service delivery characteristics of a community-based OMP for DRTB patients facilitated by CHWs as well as observed ototoxic hearing loss in this population.

METHOD:

 A descriptive retrospective record review of longitudinal ototoxicity monitoring of 194 DRTB patients undergoing treatment at community-based clinics in the city of Cape Town between 2013 and 2017.

RESULTS:

 Follow-up rates between consecutive monitoring assessments reached as high as 80.6% for patients assessed by CHWs. Few patients (14.2% - 32.6%) were assessed with the regularity (≥ 6 assessments) and frequency required for effective ototoxicity monitoring, with assessments conducted, on average, every 53.4-64.3 days. Following DRTB treatment, 51.5% of patients presented with a significant ototoxic shift meeting one or more of the American Speech-Language-Hearing Association (ASHA) criteria. Deterioration in hearing thresholds was bilateral and most pronounced at high frequencies (4 kHz - 8 kHz). The presence of pre-existing hearing loss, human immunodeficiency virus co-infection and a history of noise exposure were significant predictors of ototoxicity in patients.

CONCLUSION:

 DRTB treatment with kanamycin resulted in significant deterioration of hearing longitudinally, predominantly at high frequencies. With ongoing training and supportive supervision, CHWs can facilitate community-based ototoxicity monitoring of DRTB patients. Current protocols and guidelines may require reassessment for appropriate community-based ototoxicity monitoring.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Ototoxicity / Hearing Loss Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Africa Language: English Journal: S Afr J Commun Disord Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Ototoxicity / Hearing Loss Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Africa Language: English Journal: S Afr J Commun Disord Year: 2022 Document Type: Article